These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
158 related items for PubMed ID: 19164495
1. The role of flumazenil in the treatment of benzodiazepine dependence: physiological and psychological profiles. Hood S, O'Neil G, Hulse G. J Psychopharmacol; 2009 Jun; 23(4):401-9. PubMed ID: 19164495 [Abstract] [Full Text] [Related]
2. High dose benzodiazepine dependence: description of 29 patients treated with flumazenil infusion and stabilised with clonazepam. Quaglio G, Pattaro C, Gerra G, Mathewson S, Verbanck P, Des Jarlais DC, Lugoboni F. Psychiatry Res; 2012 Aug 15; 198(3):457-62. PubMed ID: 22424905 [Abstract] [Full Text] [Related]
3. Benzodiazepine dependence and its treatment with low dose flumazenil. Hood SD, Norman A, Hince DA, Melichar JK, Hulse GK. Br J Clin Pharmacol; 2014 Feb 15; 77(2):285-94. PubMed ID: 23126253 [Abstract] [Full Text] [Related]
5. Reversal of conscious sedation by flumazenil: current status and future prospects. McCloy RF. Acta Anaesthesiol Scand Suppl; 1995 Feb 15; 108():35-42. PubMed ID: 8693923 [Abstract] [Full Text] [Related]
6. Intravenous flumazenil following prolonged exposure to lormetazepam in humans: lack of precipitated withdrawal. Gerra G, Giucasto G, Zaimovic A, Fertonani G, Chittolini B, Avanzini P, Caccavari R, Delsignore R. Int Clin Psychopharmacol; 1996 Jun 15; 11(2):81-8. PubMed ID: 8803645 [Abstract] [Full Text] [Related]
7. Intravenous flumazenil versus oxazepam tapering in the treatment of benzodiazepine withdrawal: a randomized, placebo-controlled study. Gerra G, Zaimovic A, Giusti F, Moi G, Brewer C. Addict Biol; 2002 Oct 15; 7(4):385-95. PubMed ID: 14578014 [Abstract] [Full Text] [Related]
8. Withdrawal and psychological sequelae, and patient satisfaction associated with subcutaneous flumazenil infusion for the management of benzodiazepine withdrawal: a case series. Hulse G, O'Neil G, Morris N, Bennett K, Norman A, Hood S. J Psychopharmacol; 2013 Feb 15; 27(2):222-7. PubMed ID: 22596209 [Abstract] [Full Text] [Related]
9. Agonist substitution for high-dose benzodiazepine-dependent patients: let us not forget the importance of flumazenil. Lugoboni F, Faccini M, Quaglio G, Casari R, Albiero A, Pajusco B. Addiction; 2011 Apr 15; 106(4):853. PubMed ID: 21320225 [No Abstract] [Full Text] [Related]
10. The use of flumazenil in the anxious and benzodiazepine-dependent ECT patient. Krystal AD, Watts BV, Weiner RD, Moore S, Steffens DC, Lindahl V. J ECT; 1998 Mar 15; 14(1):5-14. PubMed ID: 9661088 [Abstract] [Full Text] [Related]
15. Slow subcutaneous infusion of flumazenil for the treatment of long-term, high-dose benzodiazepine users: a review of 214 cases. Faccini M, Leone R, Opri S, Casari R, Resentera C, Morbioli L, Conforti A, Lugoboni F. J Psychopharmacol; 2016 Oct 15; 30(10):1047-53. PubMed ID: 27166362 [Abstract] [Full Text] [Related]
16. Physical dependence in baboons chronically treated with low and high doses of diazepam. Kaminski BJ, Sannerud CA, Weerts EM, Lamb RJ, Griffiths RR. Behav Pharmacol; 2003 Jul 15; 14(4):331-42. PubMed ID: 12838039 [Abstract] [Full Text] [Related]
17. Focal nonconvulsive seizures during detoxification for benzodiazepine abuse. Albiero A, Brigo F, Faccini M, Casari R, Quaglio G, Storti M, Fiaschi A, Bongiovanni LG, Lugoboni F. Epilepsy Behav; 2012 Feb 15; 23(2):168-70. PubMed ID: 22200495 [Abstract] [Full Text] [Related]